1. Home
  2. BLCO vs HBM Comparison

BLCO vs HBM Comparison

Compare BLCO & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • HBM
  • Stock Information
  • Founded
  • BLCO 1853
  • HBM 1927
  • Country
  • BLCO Canada
  • HBM Canada
  • Employees
  • BLCO N/A
  • HBM N/A
  • Industry
  • BLCO Ophthalmic Goods
  • HBM Metal Mining
  • Sector
  • BLCO Health Care
  • HBM Basic Materials
  • Exchange
  • BLCO Nasdaq
  • HBM Nasdaq
  • Market Cap
  • BLCO 4.9B
  • HBM 4.6B
  • IPO Year
  • BLCO 2022
  • HBM N/A
  • Fundamental
  • Price
  • BLCO $15.01
  • HBM $12.72
  • Analyst Decision
  • BLCO Hold
  • HBM
  • Analyst Count
  • BLCO 11
  • HBM 0
  • Target Price
  • BLCO $15.80
  • HBM N/A
  • AVG Volume (30 Days)
  • BLCO 483.2K
  • HBM 7.0M
  • Earning Date
  • BLCO 10-29-2025
  • HBM 08-13-2025
  • Dividend Yield
  • BLCO N/A
  • HBM 0.11%
  • EPS Growth
  • BLCO N/A
  • HBM 216.33
  • EPS
  • BLCO N/A
  • HBM 0.72
  • Revenue
  • BLCO $4,891,000,000.00
  • HBM $2,202,000,000.00
  • Revenue This Year
  • BLCO $8.27
  • HBM $13.55
  • Revenue Next Year
  • BLCO $5.73
  • HBM N/A
  • P/E Ratio
  • BLCO N/A
  • HBM $17.59
  • Revenue Growth
  • BLCO 8.81
  • HBM 8.31
  • 52 Week Low
  • BLCO $10.45
  • HBM $5.95
  • 52 Week High
  • BLCO $21.69
  • HBM $12.81
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 62.34
  • HBM 76.08
  • Support Level
  • BLCO $14.53
  • HBM $11.62
  • Resistance Level
  • BLCO $15.08
  • HBM $12.47
  • Average True Range (ATR)
  • BLCO 0.33
  • HBM 0.31
  • MACD
  • BLCO 0.00
  • HBM 0.12
  • Stochastic Oscillator
  • BLCO 92.22
  • HBM 95.85

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

Share on Social Networks: